2.71 USD
-0.04 (-1.45%)
2.711 USD
+0 (+0.04%)
GDRX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of GDRX get a neutral evaluation. Nothing too spectacular is happening here. GDRX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, GDRX could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year GDRX was profitable.
In the past year GDRX had a positive cash flow from operations.
In the past 5 years GDRX reported 4 times negative net income.
GDRX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 2.40%, GDRX belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
GDRX's Return On Equity of 5.29% is amongst the best of the industry. GDRX outperforms 91.43% of its industry peers.
GDRX has a Return On Invested Capital of 5.73%. This is amongst the best in the industry. GDRX outperforms 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROIC | 5.73% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 3.97%, GDRX belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
In the last couple of years the Profit Margin of GDRX has declined.
GDRX has a better Operating Margin (10.37%) than 85.71% of its industry peers.
In the last couple of years the Operating Margin of GDRX has declined.
Looking at the Gross Margin, with a value of 93.46%, GDRX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of GDRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
GDRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for GDRX has been reduced compared to 1 year ago.
GDRX has about the same amout of shares outstanding than it did 5 years ago.
GDRX has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.42, we must say that GDRX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.42, GDRX perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
GDRX has a debt to FCF ratio of 4.66. This is a neutral value as GDRX would need 4.66 years to pay back of all of its debts.
GDRX has a Debt to FCF ratio (4.66) which is comparable to the rest of the industry.
GDRX has a Debt/Equity ratio of 0.81. This is a neutral value indicating GDRX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.81, GDRX is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Altman-Z | 0.42 |
ROIC/WACC0.55
WACC10.38%
2.3 Liquidity
GDRX has a Current Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.11, GDRX is doing good in the industry, outperforming 62.86% of the companies in the same industry.
A Quick Ratio of 3.11 indicates that GDRX has no problem at all paying its short term obligations.
The Quick ratio of GDRX (3.11) is better than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 |
3. Growth
3.1 Past
GDRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.37%, which is quite good.
GDRX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.47% yearly.
The Revenue has been growing slightly by 1.30% in the past year.
The Revenue has been growing by 15.34% on average over the past years. This is quite good.
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
3.2 Future
The Earnings Per Share is expected to grow by 25.32% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.00% on average over the next years.
EPS Next Y11.24%
EPS Next 2Y16.6%
EPS Next 3Y17.03%
EPS Next 5Y25.32%
Revenue Next Year0.14%
Revenue Next 2Y1.51%
Revenue Next 3Y3.38%
Revenue Next 5Y5%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 7.74, which indicates a rather cheap valuation of GDRX.
Compared to the rest of the industry, the Price/Earnings ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of GDRX to the average of the S&P500 Index (26.49), we can say GDRX is valued rather cheaply.
With a Price/Forward Earnings ratio of 6.04, the valuation of GDRX can be described as very cheap.
100.00% of the companies in the same industry are more expensive than GDRX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, GDRX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.74 | ||
| Fwd PE | 6.04 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GDRX is valued cheaper than 94.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, GDRX is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.77 | ||
| EV/EBITDA | 6.92 |
4.3 Compensation for Growth
GDRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GDRX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as GDRX's earnings are expected to grow with 17.03% in the coming years.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y16.6%
EPS Next 3Y17.03%
5. Dividend
5.1 Amount
No dividends for GDRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.71
-0.04 (-1.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners50.74%
Inst Owner Change-2.53%
Ins Owners11.16%
Ins Owner Change2.63%
Market Cap919.86M
Revenue(TTM)800.65M
Net Income(TTM)31.75M
Analysts76.19
Price Target5.19 (91.51%)
Short Float %8.25%
Short Ratio1.79
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.02%
Min EPS beat(2)-13.38%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.95%
Min EPS beat(4)-13.38%
Max EPS beat(4)-7.12%
EPS beat(8)2
Avg EPS beat(8)-4.79%
EPS beat(12)6
Avg EPS beat(12)4.06%
EPS beat(16)9
Avg EPS beat(16)11.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.22%
Revenue beat(8)0
Avg Revenue beat(8)-1.92%
Revenue beat(12)1
Avg Revenue beat(12)-1.83%
Revenue beat(16)2
Avg Revenue beat(16)-1.59%
PT rev (1m)-4.67%
PT rev (3m)-4.32%
EPS NQ rev (1m)-1.96%
EPS NQ rev (3m)-4.77%
EPS NY rev (1m)-3.49%
EPS NY rev (3m)-3.89%
Revenue NQ rev (1m)-0.81%
Revenue NQ rev (3m)-2.38%
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)-0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.74 | ||
| Fwd PE | 6.04 | ||
| P/S | 1.15 | ||
| P/FCF | 8.77 | ||
| P/OCF | 5.12 | ||
| P/B | 1.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.92 |
EPS(TTM)0.35
EY12.92%
EPS(NY)0.45
Fwd EY16.55%
FCF(TTM)0.31
FCFY11.41%
OCF(TTM)0.53
OCFY19.54%
SpS2.36
BVpS1.77
TBVpS-0.08
PEG (NY)0.69
PEG (5Y)N/A
Graham Number3.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROCE | 7.26% | ||
| ROIC | 5.73% | ||
| ROICexc | 7.53% | ||
| ROICexgc | 26.92% | ||
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% | ||
| FCFM | 13.11% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y37.95%
ROICexgc growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score6
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Debt/EBITDA | 2.95 | ||
| Cap/Depr | 92.2% | ||
| Cap/Sales | 9.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 109.5% | ||
| Profit Quality | 330.43% | ||
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 | ||
| Altman-Z | 0.42 |
F-Score6
WACC10.38%
ROIC/WACC0.55
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
EPS Next Y11.24%
EPS Next 2Y16.6%
EPS Next 3Y17.03%
EPS Next 5Y25.32%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
Revenue Next Year0.14%
Revenue Next 2Y1.51%
Revenue Next 3Y3.38%
Revenue Next 5Y5%
EBIT growth 1Y179.68%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year34.43%
EBIT Next 3Y16.06%
EBIT Next 5Y13.87%
FCF growth 1Y9.18%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y16.5%
OCF growth 3Y0.94%
OCF growth 5Y17.16%
GOODRX HOLDINGS INC-CLASS A / GDRX FAQ
Can you provide the ChartMill fundamental rating for GOODRX HOLDINGS INC-CLASS A?
ChartMill assigns a fundamental rating of 6 / 10 to GDRX.
Can you provide the valuation status for GOODRX HOLDINGS INC-CLASS A?
ChartMill assigns a valuation rating of 9 / 10 to GOODRX HOLDINGS INC-CLASS A (GDRX). This can be considered as Undervalued.
What is the profitability of GDRX stock?
GOODRX HOLDINGS INC-CLASS A (GDRX) has a profitability rating of 6 / 10.
What is the valuation of GOODRX HOLDINGS INC-CLASS A based on its PE and PB ratios?
The Price/Earnings (PE) ratio for GOODRX HOLDINGS INC-CLASS A (GDRX) is 7.74 and the Price/Book (PB) ratio is 1.53.
Can you provide the financial health for GDRX stock?
The financial health rating of GOODRX HOLDINGS INC-CLASS A (GDRX) is 5 / 10.